Der fandtes ikke tegn på neutralisation af lepirudin eller på en allergisk reaktion associeret med det positive antistoffund.
No evidence of a neutralisation of lepirudin or of an allergic reaction associated with the positive antibody test results was found. – Experience of combined therapy with thrombolytic agents in patients with HIT type II is very limited.